Home Featured Page 147

Featured

Latest

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on FDA, Election Year and ‘Ibogaine Exceptionalism’

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

Gov. Spencer Cox Signs Utah’s H.B. 390 Into Law, Authorizing Psychedelic Research for Veterans With PTSD

Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives...

COMPASS Pathways Announces Phase 3 Pivotal Program Design for COMP360 in...

Clearmind Medicine Featured in “Psychedelics Tonight,” Streaming on ALTRD.TV

PsyBio Therapeutics Reaches Agreement to Conduct Initial Psilocybin Clinical Trial

PT363 – Reggie Harris – Cannabis and Psilocybin: The Complications of...

Optimi Health Announces Closing of Strategic Non-Brokered Private Placement

Silo Pharma Initiates Toxicity Study of its Proprietary Ketamine Formulation for...

The Fifteenth Horizons is Right Around the Corner

Numinus to Participate in a Water Tower Research Fireside Chat on...

Reunion Neuroscience Inc. Announces Executive Changes

EDITOR PICKS

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on...

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research,...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on FDA, Election Year and ‘Ibogaine Exceptionalism’

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

Gov. Spencer Cox Signs Utah’s H.B. 390 Into Law, Authorizing Psychedelic Research for Veterans With PTSD

ShroomskiCon 2026

Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives...

COMPASS Pathways Announces Phase 3 Pivotal Program Design for COMP360 in...

Clearmind Medicine Featured in “Psychedelics Tonight,” Streaming on ALTRD.TV

PsyBio Therapeutics Reaches Agreement to Conduct Initial Psilocybin Clinical Trial

PT363 – Reggie Harris – Cannabis and Psilocybin: The Complications of...

Optimi Health Announces Closing of Strategic Non-Brokered Private Placement

Silo Pharma Initiates Toxicity Study of its Proprietary Ketamine Formulation for...

The Fifteenth Horizons is Right Around the Corner

Numinus to Participate in a Water Tower Research Fireside Chat on...

Reunion Neuroscience Inc. Announces Executive Changes

EDITOR PICKS

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on...

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research,...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY